UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in IMVT — Immunovant, Inc.
CIK 861177
NEW YORK, NY
Position in IMVT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,520,520
+$103,033 QoQ
Shares Held
141,728
+5.4% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 44%
Shared 0%
None 56%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,605,811 across 211 Biotechnology names. IMVT ranks #83 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in IMVT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,520,520 | 141,728 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,417,487 | 134,441 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,728,448 | 107,224 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,204,160 | 200,260 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,394,151 | 140,091 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $6,917,068 | 279,252 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,861,760 | 310,830 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,461,408 | 320,508 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,656,859 | 206,031 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,744,162 | 207,552 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,183,142 | 82,916 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $981,164 | 51,722 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $802,206 | 51,722 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $776,632 | 43,754 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $208,385 | 37,345 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $202,572 | 51,942 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $286,198 | 51,942 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $442,544 | 51,942 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $451,374 | 51,942 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $636,281 | 60,197 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $698,493 | 43,547 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,061,967 | 44,641 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $703,800 | 20,000 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $216,715 | 8,900 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||